Barclays initiated coverage on Kate Spade & Co (NYSE: KATE) with an Overweight rating and a price target of $50.00.Barclays initiated coverage on Kate Spade & Co (NYSE: KATE) with an Overweight rating and a price target of $50.00. Kate Spade & Co (NYSE:KATE) shares after opening at $39.95 moved to $39.99 on last trade day and at the end of the day closed at $39.06. Company price to sales ratio in past twelve months was calculated as 3.79 and price to cash ratio as 36.84. Kate Spade & Co (NYSE:KATE) showed a positive weekly performance of 4.86%.
Barrington Research cut shares of Golden Star Resources Ltd (USA) (NYSE:GSS) to a market perform rating in a research report sent to investors on Wednesday morning, Analyst RN reports. Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) shares fell -11.60% in last trading session and ended the day on $0.598. Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) return on equity ratio is recorded as -114.40% and its return on assets is -55.70%. Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) yearly performance is-64.22%.
The biggest winner on the market Friday was Endocyte Inc (NASDAQ:ECYT ) by a long shot, as shares absolutely exploded, closing upwards of 90% for the day. The market was celebrating a successful phase 2 clinical trial of the company’s drug vintafolide in its lung cancer indication. Endocyte, Inc. (NASDAQ:ECYT) shares moved up 92.42% in last trading session and was closed at $28.17, while trading in range of $25.88 – $33.70. Endocyte, Inc. (NASDAQ:ECYT) year to date (YTD) performance is 163.76%.
Stock analysts at Cowen and Company hoisted their price target on shares of McEwen Mining Inc (NYSE:MUX) from $4.23 to $4.57 in a report issued on Friday, American Banking and Market News reports. Cowen and Company’s target price would suggest a potential upside of 71.16% from the stock’s previous close. McEwen Mining Inc (NYSE:MUX) weekly performance is -19.10%. On last trading day company shares ended up $2.88. McEwen Mining Inc (NYSE:MUX) distance from 50-day simple moving average (SMA50) is 4.49%. Analysts mean target price for the company is $4.57.
Leave a Reply